Literature DB >> 28859335

A New Mutation in FIG4 Causes a Severe Form of CMT4J Involving TRPV4 in the Pathogenic Cascade.

Benoit J Gentil1, Erin O'Ferrall1, Colin Chalk1, Luis F Santana1, Heather D Durham1, Rami Massie1.   

Abstract

Mutations in FIG4, coding for a phosphoinositol(3,5) bisphosphate 5' phosphatase and involved in vesicular trafficking and fusion, have been shown causing a recessive form of Charcot-Marie-Tooth (CMT). We have identified a novel intronic mutation in the FIG4 in a wheel-chair bound patient presenting with a severe form of CMT4J and provide a longitudinal study. Investigations indicated a demyelinating sensorimotor polyneuropathy with diffuse active denervation and severe axonal loss. Genetic testing revealed that the patient is heterozygous for 2 FIG4 mutations, p.I41T and a T > G transversion at IVS17-10, the latter predicted to cause a splicing defect. FIG4 was severely diminished in patient's fibroblasts indicating loss-of-function. Consistent with FIG4's function in phosphoinositol homeostasis and vesicular trafficking, fibroblasts contained multiple large vacuoles and vesicular organelles were abnormally dispersed. FIG4 deficiency has implications for turnover of membrane proteins. The transient receptor cation channel, TRPV4, accumulated at the plasma membrane of patient's fibroblasts due to slow turnover. Knocking down Fig4 in murine cultured motor neurons resulted in vacuolation and cell death. Inhibiting TRPV4 activity significantly preserved viability, although not correcting vesicular trafficking. In conclusion, we demonstrate a new FIG4 intronic mutation and, importantly, a functional interaction between FIG4 and TRPV4.
© 2017 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Charcot–Marie–Tooth disease; Endosomes; FIG4; Motor neurons; Phosphoinositol(3,5) biphosphate; TRPV4

Mesh:

Substances:

Year:  2017        PMID: 28859335      PMCID: PMC6251583          DOI: 10.1093/jnen/nlx062

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  31 in total

1.  OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity.

Authors:  R Strotmann; C Harteneck; K Nunnenmacher; G Schultz; T D Plant
Journal:  Nat Cell Biol       Date:  2000-10       Impact factor: 28.824

2.  Localization of phosphatidylinositol 3-phosphate in yeast and mammalian cells.

Authors:  D J Gillooly; I C Morrow; M Lindsay; R Gould; N J Bryant; J M Gaullier; R G Parton; H Stenmark
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

Review 3.  Phosphatidylinositol-3,5-bisphosphate: no longer the poor PIP2.

Authors:  Cheuk Y Ho; Tamadher A Alghamdi; Roberto J Botelho
Journal:  Traffic       Date:  2011-07-27       Impact factor: 6.215

4.  CMT2C with vocal cord paresis associated with short stature and mutations in the TRPV4 gene.

Authors:  D-H Chen; Y Sul; M Weiss; A Hillel; H Lipe; J Wolff; M Matsushita; W Raskind; T Bird
Journal:  Neurology       Date:  2010-11-30       Impact factor: 9.910

5.  Identification of pleckstrin-homology-domain-containing proteins with novel phosphoinositide-binding specificities.

Authors:  S Dowler; R A Currie ; D G Campbell ; M Deak; G Kular; C P Downes; D R Alessi
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

6.  Osmotic stress activates phosphatidylinositol-3,5-bisphosphate synthesis.

Authors:  S K Dove; F T Cooke; M R Douglas; L G Sayers; P J Parker; R H Michell
Journal:  Nature       Date:  1997-11-13       Impact factor: 49.962

7.  Rescue of neurodegeneration in the Fig4 null mouse by a catalytically inactive FIG4 transgene.

Authors:  Guy M Lenk; Christen M Frei; Ashley C Miller; Rachel C Wallen; Yevgeniya A Mironova; Roman J Giger; Miriam H Meisler
Journal:  Hum Mol Genet       Date:  2015-11-24       Impact factor: 6.150

8.  An orally active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failure.

Authors:  Kevin S Thorneloe; Mui Cheung; Weike Bao; Hasan Alsaid; Stephen Lenhard; Ming-Yuan Jian; Melissa Costell; Kristeen Maniscalco-Hauk; John A Krawiec; Alan Olzinski; Earl Gordon; Irina Lozinskaya; Lou Elefante; Pu Qin; Daniel S Matasic; Chris James; James Tunstead; Brian Donovan; Lorena Kallal; Anna Waszkiewicz; Kalindi Vaidya; Elizabeth A Davenport; Jonathan Larkin; Mark Burgert; Linda N Casillas; Robert W Marquis; Guosen Ye; Hilary S Eidam; Krista B Goodman; John R Toomey; Theresa J Roethke; Beat M Jucker; Christine G Schnackenberg; Mary I Townsley; John J Lepore; Robert N Willette
Journal:  Sci Transl Med       Date:  2012-11-07       Impact factor: 17.956

Review 9.  Endosomal phosphoinositides and human diseases.

Authors:  Anne-Sophie Nicot; Jocelyn Laporte
Journal:  Traffic       Date:  2008-04-21       Impact factor: 6.215

10.  IP3 sensitizes TRPV4 channel to the mechano- and osmotransducing messenger 5'-6'-epoxyeicosatrienoic acid.

Authors:  Jacqueline Fernandes; Ivan M Lorenzo; Yaniré N Andrade; Anna Garcia-Elias; Selma A Serra; José M Fernández-Fernández; Miguel A Valverde
Journal:  J Cell Biol       Date:  2008-03-31       Impact factor: 10.539

View more
  7 in total

1.  Myelin abnormality in Charcot-Marie-Tooth type 4J recapitulates features of acquired demyelination.

Authors:  Bo Hu; Megan McCollum; Vignesh Ravi; Sezgi Arpag; Daniel Moiseev; Ryan Castoro; Bret Mobley; Bryan Burnette; Carly Siskind; John Day; Robin Yawn; Shawna Feely; Yuebing Li; Qing Yan; Michael Shy; Jun Li
Journal:  Ann Neurol       Date:  2018-03-30       Impact factor: 10.422

2.  Severe Consequences of SAC3/FIG4 Phosphatase Deficiency to Phosphoinositides in Patients with Charcot-Marie-Tooth Disease Type-4J.

Authors:  Assia Shisheva; Diego Sbrissa; Bo Hu; Jun Li
Journal:  Mol Neurobiol       Date:  2019-07-16       Impact factor: 5.590

Review 3.  Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders.

Authors:  Sudhanshu P Raikwar; Nidhi S Kikkeri; Ragha Sakuru; Daniyal Saeed; Haris Zahoor; Keerthivaas Premkumar; Shireen Mentor; Ramasamy Thangavel; Iuliia Dubova; Mohammad Ejaz Ahmed; Govindhasamy P Selvakumar; Duraisamy Kempuraj; Smita Zaheer; Shankar S Iyer; Asgar Zaheer
Journal:  J Neuroimmune Pharmacol       Date:  2019-04-23       Impact factor: 4.147

Review 4.  Roles of PIKfyve in multiple cellular pathways.

Authors:  Pilar Rivero-Ríos; Lois S Weisman
Journal:  Curr Opin Cell Biol       Date:  2022-05-16       Impact factor: 8.386

5.  Charcot Marie Tooth disease type 4J with complex central nervous system features.

Authors:  James P Orengo; Pravin Khemani; John W Day; Jun Li; Carly E Siskind
Journal:  Ann Clin Transl Neurol       Date:  2018-01-22       Impact factor: 4.511

6.  Whole exome sequencing establishes diagnosis of Charcot-Marie-Tooth 4J, 1C, and X1 subtypes.

Authors:  Kleita Michaelidou; Ioannis Tsiverdis; Sophia Erimaki; Dimitra Papadimitriou; Georgios Amoiridis; Alexandros Papadimitriou; Panayiotis Mitsias; Ioannis Zaganas
Journal:  Mol Genet Genomic Med       Date:  2020-02-05       Impact factor: 2.183

7.  Clinical and Genetic Analysis of a Patient with CMT4J.

Authors:  Leema Reddy Peddareddygari; Raji P Grewal
Journal:  Neurol Int       Date:  2022-02-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.